(Q44772565)

6 December 2017

0 references

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency? (English)

1 reference

6 December 2017

1

1 reference

6 December 2017

3

1 reference

6 December 2017

Asghar Aghamohammadi

2

0 references

publication date

10 December 2013

1 reference

Expert Review of Clinical Immunology

6 December 2017

published in

1 reference

6 December 2017

volume

10

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

1-5

1 reference

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Genome-wide association identifies diverse causes of common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Treatment of hypogammaglobulinemia in adults: a scoring system to guide decisions on immunoglobulin replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Prioritization of evidence-based indications for intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Controversies in IgG replacement therapy in patients with antibody deficiency diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Clinical ambiguities--ongoing questions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

Key aspects for successful immunoglobulin therapy of primary immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.870478

10.1586/1744666X.2014.870478

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference